@idcard.bsky.social
Post Treatment Blood Cultures in Patients with Infective Endocarditis: Valuable, Inconsequential or Worse?
✅ Just Accepted
🔗 https://doi.org/10.1093/cid/ciaf618?utmsource=x&utmmedium=organic-social&utmcontent=%40CIDJournal&utmcampaign=CID-Article-Promotion
✅ Just Accepted
🔗 https://doi.org/10.1093/cid/ciaf618?utmsource=x&utmmedium=organic-social&utmcontent=%40CIDJournal&utmcampaign=CID-Article-Promotion
November 16, 2025 at 3:49 AM
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
✅ Just Accepted
✅ Just Accepted
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial
Post-exposure doxycycline-based prophylaxis was associated with a significant increase in the frequency of N. gonorrhoeae isolates with high-level resistan
bit.ly
November 16, 2025 at 3:49 AM
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults
✅ Just Accepted
🔗 https://bit.ly/48aRxTS
✅ Just Accepted
🔗 https://bit.ly/48aRxTS
November 16, 2025 at 3:49 AM
November 16, 2025 at 3:47 AM
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
This nationwide study of 2,027 Danish patients with MAC isolates (1991-2018) revealed declining mortality. Age, male sex, DMAC, and comorbidities were asso
bit.ly
November 9, 2025 at 3:29 AM
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
#IDSky
#IDSky
A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 and has since spread worldwide
bit.ly
November 9, 2025 at 3:29 AM
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
November 9, 2025 at 3:27 AM
Characteristics and anti-adhesion activity of chicken scFv antibodies against Helicobacter pylori HpaA
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
✅ Just Accepted
🔗 https://bit.ly/3JKv8U6
November 9, 2025 at 3:26 AM
Together with previous modules on #HIV testing and #PrEP, these additions complete a comprehensive framework for modern HIV care across Europe.
They support consistent, equitable standards for prevention, treatment, and lifelong health.
🔗 Access all modules here: bit.ly/4niRUAa
#StandardsOfCare
They support consistent, equitable standards for prevention, treatment, and lifelong health.
🔗 Access all modules here: bit.ly/4niRUAa
#StandardsOfCare
ECDC/EACS standards of HIV care
The standards of care (SoC) for HIV define the expected, or desired, quality of prevention, treatment, and care for people at risk of HIV acquisition or living with HIV.
bit.ly
November 9, 2025 at 3:26 AM
Serum markers of fibroinflammatory activity PRO-C3 and CPa9-HNE are associated with liver-related outcomes in patients with Chronic Hepatitis C
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
✅ Just Accepted
🔗 https://bit.ly/4nH3XaI
November 9, 2025 at 3:25 AM
Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa
✅ Just Accepted
🔗 https://bit.ly/3JhtYzq
✅ Just Accepted
🔗 https://bit.ly/3JhtYzq
November 9, 2025 at 3:23 AM
FDA approves new IV antibiotic for complicated urinary tract infections
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
FDA approves new IV antibiotic for complicated urinary tract infections
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic classes.
www.cidrap.umn.edu
November 6, 2025 at 7:35 PM
Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study
#IDSky
#IDSky
Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study
We use a mathematical model incorporating racial inequities in the United States to determine the effects of interventions aimed at ameliorating inequity i
bit.ly
November 4, 2025 at 6:04 PM
Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55?Induced Respiratory Disease
✅ Just Accepted
🔗 https://bit.ly/492tSWH
✅ Just Accepted
🔗 https://bit.ly/492tSWH
November 4, 2025 at 6:03 PM
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization
Autoantibodies against type I interferons, MPO and ACE2 are associated with COVID-19 severity and poor outcomes, show increasing titers overtime, and corre
bit.ly
October 17, 2025 at 11:25 PM
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo Study
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WF11QL
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WF11QL
October 17, 2025 at 11:24 PM
Household Molecular Epidemiology of Streptococcus pyogenes Carriage and Infection in The Gambia
#IDSky
#IDSky
Household Molecular Epidemiology of Streptococcus pyogenes Carriage and Infection in The Gambia
First molecular analysis of S pyogenes skin carriage in Africa. Skin carriage may be an important reservoir in RHD-endemic settings. · Highest strain diver
bit.ly
October 7, 2025 at 1:59 AM
October 7, 2025 at 1:58 AM
Insights on recurrent and sequential Clostridioides difficile infections from genomic surveillance in Minnesota, USA, 2019-2021
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46zgcB0
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46zgcB0
October 7, 2025 at 1:57 AM
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gPh0oz
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gPh0oz
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial
AbstractBackground. The duration of infectiousness following pulmonary tuberculosis treatment initiation remains uncertain. We aimed to assess whether a bu
bit.ly
October 7, 2025 at 1:54 AM
Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
September 27, 2025 at 3:09 AM
Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital
In a resource-limited setting at Siriraj Hospital, a cluster-randomized trial in six medical wards compared enhanced CRE prevention—including education, al
bit.ly
September 27, 2025 at 3:08 AM
Monkeypox virus shedding despite tecovirimat treatment in a cohort in Toronto, Canada
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gidGCe
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gidGCe
September 15, 2025 at 2:22 PM
HIV resistance to dolutegravir varies with co-administered agents
✅ Just Accepted
#IDSky
https://bit.ly/4n0HvtF
✅ Just Accepted
#IDSky
https://bit.ly/4n0HvtF
HIV resistance to dolutegravir varies with co-administered agents
We hypothesized that HIV-dolutegravir-resistance is more frequent when co-administered with nucleos(t)ides with shorter intracellular half-lives.
bit.ly
September 15, 2025 at 2:21 PM
In CID, Maria Ines Figueroa and colleagues evaluated the antiviral activity of dolutegravir/lamivudine among antiretroviral therapy (ART)-naive patients with HIV with a CD4 count ≤200 cells/mm³. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf415/8241230
September 12, 2025 at 4:03 PM